J9211 Idarubicin hcl injection
Also known as: idarubicin, Idamycin
Intravenous injection of idarubicin hydrochloride, an anthracycline topoisomerase II inhibitor.
In Plain Language
red chemotherapy drug; acute leukemia treatment
Clinical Context
Used for acute myeloid leukemia and acute lymphoblastic leukemia.
RVU Information
CPT J9211 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J9211?
CPT J9211 (Idarubicin hcl injection) is a J Codes (Drugs) code. Intravenous injection of idarubicin hydrochloride, an anthracycline topoisomerase II inhibitor.
How is J9211 administered?
CPT J9211 is administered by a healthcare provider, typically via injection or infusion. Used for acute myeloid leukemia and acute lymphoblastic leukemia. It is used by Hematology/Oncology, Medical Oncology.
When is CPT J9211 used?
Used for acute myeloid leukemia and acute lymphoblastic leukemia.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and export board-ready case logs — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.